Skip to main content

$26M To A Sarpy County Family In a Medical Malpractice Suit

$26M To A Sarpy County Family In a Medical Malpractice Suit

$26M To A Sarpy County Family In a Medical Malpractice Suit

Introduction

A Sarpy County family has been awarded $26.1 million by a Douglas County jury against Children’s Hospital and Medical Center in Omaha for the facility's carelessness that resulted in permanent disability to a child.

As per the court documents, one of the doctors working in the hospital improperly discharged the 5-year-old child in 2017 post her treatment after she suffered an accidental fall, resulting in brain trauma for her. The child will receive $21.5 million as lifetime medical care, and the parents will get another $4.6 million to take care of her.

The family of the child stated that two days after being sent home from the hospital post the treatment, the child suffered from irreparable brain damage, severe seizures, blindness, difficulty in communicating and became wheelchair bound.

The Children’s Hospital stated that it sympathizes with the child's suffering, but their team was efficient enough to provide the required standard of care to the child during the treatment.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!